Yeast Display
Yeast Display Library | High-Affinity Antibody Discovery
Expanding Antibody Discovery
Our advanced platforms, now including Yeast Display, maximize binder diversity and affinity, accelerating the discovery of high-quality antibodies for therapeutic development.
newly added technology
Yeast Display for Antibody Discovery
Our Yeast Display technology enhances antibody discovery by enabling the identification of high-affinity binders with exceptional precision. Complementing our well-established phage libraries and antibody optimization platforms, it maximizes both binder diversity and affinity, accelerating the path to potent therapeutic candidates. This advanced approach ensures a more comprehensive discovery process, delivering optimized antibodies with superior characteristics.
Yeast Display Library
Our Yeast Display platform streamlines antibody discovery by combining the power of phage display with high-throughput yeast screening. Starting with our well-established phage libraries, we enrich and clone diverse antibody candidates into yeast display vectors, enabling the direct screening of millions of variants. This approach ensures the selection of high-affinity binders with optimized characteristics for therapeutic development.
Our Yeast Display antibody discovery process includes:
Utilizing our SuperHuman™, Cosmic™, or Tungsten™ VHH libraries to generate a highly diverse pool of candidates suitable for yeast display screening.
Cloning the selected output into yeast display vectors and isolating high-affinity binders through FACS screening.
Identifying unique clones with confirmed antigen binding through precise yeast cell sorting and characterization.
Streamlining candidate selection without the need for reformatting or cloning, offering flow cytometry-based binding validation, affinity ranking, and kinetics analysis.